GontiÑas, Rufino C.
HRN: 25-99-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/30/2025
10/20/2025
IV
2.25g
Q8h
Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No No Infection Treatment Duration Error
Final appropriateness: Yes
Overall appropriateness: Yes